XM does not provide services to residents of the United States of America.

Bluetongue virus threatens Sardinia's historic sheep farming industry



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Bluetongue virus threatens Sardinia's historic sheep farming industry</title></head><body>

Sardinia accounts for 40% of Italian sheep farming

Spread of bluetongue virus supported by global warming

Failed vaccinations due to multiple virus strains

Virus killed 40,000 sheep in 2024, just 5,000 in 2023

Farmers call for government compensation amid severe losses

By Antonella Cinelli and Valentina Consiglio

ROME, Nov 5 (Reuters) -On the island of Sardinia, a bedrock of Italian sheep farming, breeder Michela Dessi has seen 150 of her flock die and 140 lose their lambs in the last few months due to an insect-borne disease called bluetongue that is ravaging local livestock.

Sardinia is home to three million sheep, almost double the number of people, and accounts for 40% of Italy's sheep population. The industry employs more than 27,000 people and is an intrinsic part of the Mediterranean island's cultural identity, thanks to products such as the salty "pecorino" cheese made with sheep's milk.

All of this is threatened by the viral infection, which has hit around a quarter of Sardinia's 13,000 sheep farms this year, killing 40,000 sheep and lambs, compared to just 5,000 in 2023.

"The sheep start to get sick, lame, come down with fever, and die after a few hours or days, sometimes suffocated by their own saliva," said Dessi, who has been running the family farm in the south of the island since 2007, with 600 sheep.

Other symptoms of the disease, which also affects cattle with less deadly consequences, are mouth ulcers, discharge from the mouth and nose, and the blueness of the tongue from which it gets its name.

Bluetongue outbreaks have occurred in several parts of Europe in recent months, helped by global warming, which favours the proliferation of the vector insect - but nowhere with such a devastating impact as in Sardinia.

The disease, which does not affect humans or the safety of animal meat or milk, was first reported in the 18th century in South Africa and arrived in Italy in 2000.

The vehicle for the virus is a tiny 1-3 millimetre-long insect called Culicoides, which is now prospering not only in summer but also into the autumn as the Mediterranean basin becomes hotter.

"Sardinia has been particularly affected, with an exponential contagion we have never seen before" said Luca Saba, the local head of the Italian agriculture lobby group Coldiretti. "And the emergency is far from over".


FAILED VACCINATIONS

The many strains of the virus are thwarting attempts to halt its spread through vaccination.

"There are 27 serotypes in the world and we cannot know if a different one will appear from one year to the next," said Sandro Rolesu, health director of the Experimental Zooprophylactic Institute of Sardinia.

"We were vaccinating for type 8, which was present last year, and we ended up with type 3," he said, adding that Italy will be vaccinating for type 3 next year.

Giovanni Filippini, head of the health ministry's animal welfare department, said the government is working on an emergency plan "based on predictive models that can prevent the spread" of bluetongue, but declined to provide details.

Meanwhile farmers already hit by one of Sardinia's driest ever summers are counting the cost and calling on Rome for financial help.

Sardinia's agriculture chief Gianfranco Satta said the island's regional government had set aside 13.5 million euros ($14.7 million) to compensate affected farmers, but Coldiretti estimates losses as high as 25 million.

"We are on our knees and companies are closing," said Roberto Congia, an official with the Sardinian Shepherds' Movement, a local lobby group.

($1 = 0.9246 euros)



Editing by Gavin Jones and Alexandra Hudson

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.